Persistent COVID-19 registry study in Navarre
Part of Infections clinical trials.
This study is a registry for people in Navarre, Spain, who have long-lasting COVID-19 symptoms (more than 3 months). By joining, you help doctors learn more about persistent COVID and how to care for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed COVID-19 infection (tested positive).
- Your symptoms have lasted more than 3 months after the infection.
- You are experiencing at least one symptom from a provided checklist.
- The symptoms you have now were not present before you got COVID-19.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common long-term COVID symptoms are in people across the Canary Islands. It may help researchers better understand who is affected and what symptoms last, which can support future care.
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
Hear when a new Long COVID Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.